BioCryst Pharmaceuticals (BCRX) Financials: Revenue & Earnings

BCRX price $8.30 +0.20 +2.53%

Ticker
BCRX
Price
$8.30
Change
+0.20 +2.53%
Market cap ?
$2.12B
P/E ?
-5.32
Forward P/E ?
14.89
Dividend yield ?
0.00%
Beta ?
0.55
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
2635300025186000206530004883500017812000157170000270827000331412000450712000874837000

BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing novel, orally administered, small-molecule therapeutics. The company currently markets two key products: Peramivir injection: An intravenous neuraminidase inhibitor, sold under the brand names RAPIVAB, RAPIACTA, and PERAMIFLU, used for the treatment of acute uncomplicated influenza. ORLADEYO: An oral serine protease…

Fair value

BCRX fair value $18.25. Price $8.30. Price is 55% below fair value.

Below fair value, around its usual discount.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare BCRX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—0.09—165.67M
2026-08-050.300.15218.25M183.28M
2026-05-06-2.980.06156.41M151.12M
2026-02-261.120.07406.56M151.32M
2025-11-030.060.07159.40M151.32M
2025-08-040.020.03163.35M149.82M
2025-05-050.00-0.07145.53M149.72M
2025-02-24-0.13-0.07131.53M126.64M
2024-11-04-0.07-0.07117.08M127.72M
2024-08-05-0.06-0.19109.33M98.32M
2024-05-06-0.17-0.2392.76M85.60M
2024-02-26-0.28-0.2493.40M90.01M
2023-11-02-0.19-0.2586.74M85.95M
2023-08-03-0.24-0.2382.49M81.42M
2023-05-03-0.28-0.3068.78M71.68M
2023-02-21-0.38-0.1979.55M75.23M
2022-11-01-0.23-0.3275.83M74.78M
2022-08-04-0.32-0.3665.53M63.33M
2022-05-05-0.40-0.3949.92M51.36M
2022-02-23-0.10-0.3147.16M51.06M
2021-11-03-0.33-0.3040.99M40.22M
2021-08-05-0.24-0.2249.96M28.67M
2021-05-06-0.36-0.2619.06M5.29M
2021-02-25-0.34-0.254.02M17.52M
2020-11-05-0.26-0.256.10M1.23M
2020-08-06-0.24-0.282.87M2.99M
2020-05-06-0.24-0.264.82M4.82M
2020-03-05-0.02-0.2539.73M516.42M
2019-11-06-0.34-0.311.77M1.67M
2019-08-06-0.34-0.311.45M1.32M
2019-05-08-0.28-0.285.89M5.68M
2019-03-04-0.25-0.262.73M2.73M
2018-11-06-0.28-0.251.45M1.35M
2018-08-07-0.19-0.2312.49M15.78M
2018-05-08-0.26-0.163.98M2.91M
2018-02-27-0.20-0.143.89M2.92M
2017-11-07-0.18-0.178.76M9.25M
2017-08-07-0.21-0.193.10M2.80M
2017-05-04-0.19-0.209.44M8.94M
2017-02-27-0.06-0.258.98M34.43M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-12-17Dullinger RonaldOther255.05K$7.131.82M
2026-08-31Stonehouse Jon PBuy644$9.706.25K
2026-08-31Milne Jill C.Buy1.29K$9.7012.49K
2026-08-31MILANO VINCENTBuy1.16K$9.7011.24K
2026-08-31McKee Amy EBuy644$9.706.25K
2026-08-31Frank StevenBuy1.29K$9.7012.49K
2026-06-11Milne Jill C.Buy33.54K$8.50285.09K
2026-06-11Milne Jill C.Buy15.29K——
2026-06-11Galson Steven KBuy33.54K$8.50285.09K
2026-06-11Galson Steven KBuy15.29K——
2026-06-11LEVIN ALAN GBuy15.29K——
2026-06-11LEVIN ALAN GBuy33.54K$8.50285.09K
2026-06-11Frank StevenBuy15.29K——
2026-06-11Frank StevenBuy33.54K$8.50285.09K
2026-06-11SANDERS MACHELLEBuy15.29K——
2026-06-11SANDERS MACHELLEBuy33.54K$8.50285.09K
2026-06-11MILANO VINCENTBuy15.29K——
2026-06-11MILANO VINCENTBuy33.54K$8.50285.09K
2026-06-11Stonehouse Jon PBuy15.29K——
2026-06-11Stonehouse Jon PBuy33.54K$8.50285.09K
2026-06-11McKee Amy EBuy15.29K——
2026-06-11McKee Amy EBuy33.54K$8.50285.09K
2026-06-11HEGGIE THERESABuy15.29K——
2026-06-11HEGGIE THERESABuy33.54K$8.50285.09K
2026-05-29Milne Jill C.Buy1.26K$8.9111.24K
2026-05-29Stonehouse Jon PBuy631$8.915.62K
2026-05-29McKee Amy EBuy631$8.915.62K
2026-05-29MILANO VINCENTBuy1.12K$8.9110.00K
2026-05-29Frank StevenBuy1.26K$8.9111.24K
2026-05-18McKee Amy ESell11.18K$8.97100.28K
2026-05-13Barnes Alane PBuy62.50K$5.04315.00K
2026-05-13Barnes Alane PSell62.50K$9.54596.25K
2026-05-13Barnes Alane PSell62.50K$5.04315.00K
2026-04-06Menon SandeepBuy441.35K$9.474.18M
2026-04-06Menon SandeepBuy205.15K——
2026-04-06Menon SandeepOther0——
2026-03-20HEGGIE THERESABuy49.93K$6.30314.58K
2026-03-20HEGGIE THERESASell49.93K$10.11504.82K
2026-03-20HEGGIE THERESASell49.93K$6.30314.58K
2026-03-16Barnes Alane PBuy150.00K$5.51826.50K
2026-03-16Barnes Alane PSell150.00K$9.151.37M
2026-03-16Barnes Alane PSell150.00K$5.51826.50K
2026-03-02Stonehouse Jon PBuy306.00K$3.22985.30K
2026-03-02Stonehouse Jon PSell306.00K$8.642.64M
2026-03-02Stonehouse Jon PSell306.00K$3.22985.30K
2026-02-27Milne Jill C.Buy528$8.754.62K
2026-02-27Stonehouse Jon PBuy421$8.753.68K
2026-02-27MILANO VINCENTBuy848$8.757.42K
2026-02-27Frank StevenBuy1.28K$8.7511.24K
2026-02-27McKee Amy EBuy642$8.755.62K
2026-01-23Milne Jill C.Buy26.68K$6.79181.18K
2026-01-23Milne Jill C.Buy12.27K——
2026-01-23Milne Jill C.Buy2.58K$8.5522.08K
2026-01-23Milne Jill C.Other0——
2026-01-01Dullinger RonaldOther0——
2025-12-22Barnes Alane PSell21.77K$7.65166.56K
2025-12-22Gayer Charles KBuy50.00K$5.51275.50K
2025-12-22Gayer Charles KBuy10.09K$5.0450.86K
2025-12-22Gayer Charles KBuy14.14K$3.2245.54K
2025-12-22Gayer Charles KSell10.09K$5.0450.86K
2025-12-22Gayer Charles KSell14.14K$3.2245.54K
2025-12-22Gayer Charles KSell50.00K$5.51275.50K
2025-12-19Dullinger RonaldOther68.50K$7.39506.21K
2025-12-19Stonehouse Jon PSell61.79K$7.41457.89K
2025-12-19Barnes Alane PSell16.90K$7.41125.24K
2025-12-19Gayer Charles KSell11.48K$7.4185.04K
2025-12-18Stonehouse Jon PSell20.00K——
2025-12-18Stonehouse Jon PBuy10.00K——
2025-12-17Gayer Charles KBuy986.95K$7.137.04M
2025-12-17Gayer Charles KBuy471.00K——
2025-12-17Barnes Alane PBuy121.70K——
2025-12-17Barnes Alane PBuy255.05K$7.131.82M
2025-12-17Ghias BabarBuy355.05K$7.132.53M
2025-12-17Ghias BabarBuy121.70K——
2025-12-15Barnes Alane PSell21.21K$7.65162.26K
2025-12-12Gayer Charles KSell8.18K$7.5761.93K
2025-12-12Barnes Alane PSell8.54K$7.5764.65K
2025-12-12Stonehouse Jon PSell27.37K$7.57207.18K
2025-12-03Barnes Alane PSell19.77K$7.65151.24K
2025-12-02Barnes Alane PSell50.91K$7.21367.22K
2025-12-01Barnes Alane PBuy91.00K$3.22293.03K
2025-12-01Barnes Alane PSell91.00K$7.10646.51K
2025-12-01Barnes Alane PSell91.00K$3.22293.03K
2025-11-28McKee Amy EBuy783$7.185.62K
2025-11-28Frank StevenBuy1.57K$7.1811.24K
2025-11-28MILANO VINCENTBuy783$7.185.62K
2025-11-13SANDERS MACHELLESell9.60K$7.1468.54K
2025-08-29McKee Amy EBuy676$8.315.62K
2025-08-29Frank StevenBuy1.35K$8.3111.24K
2025-08-29MILANO VINCENTBuy676$8.315.62K
2025-08-13HEGGIE THERESABuy40.00K$5.41216.40K
2025-08-13HEGGIE THERESABuy30.00K$2.9187.30K
2025-08-13HEGGIE THERESASell70.00K$8.51595.87K
2025-08-13HEGGIE THERESASell30.00K$2.9187.30K
2025-08-13HEGGIE THERESASell40.00K$5.41216.40K
2025-07-24Ghias BabarBuy305.00K$8.552.61M
2025-07-24Ghias BabarBuy147.00K——
2025-07-07Ghias BabarOther0——
2025-06-12SANDERS MACHELLEBuy12.50K——
2025-06-12SANDERS MACHELLEBuy27.18K$10.40282.68K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 335, holders +18 vs prior quarter. Ownership 108.95%.

HolderSharesChangeChange %Value
BLACKROCK, INC.23.89M1.24M+5.48%238.93M
RA CAPITAL MANAGEMENT, L.P.15.83M00.00%158.27M
STATE STREET CORP15.19M2.98M+24.43%151.91M
DEERFIELD MANAGEMENT COMPANY, L.P.15.10M58.40K+0.39%150.96M
VANGUARD CAPITAL MANAGEMENT LLC11.36M228.47K+2.05%113.64M
VANGUARD PORTFOLIO MANAGEMENT LLC11.14M-105.47K-0.94%111.39M
TCG CROSSOVER MANAGEMENT, LLC11.02M00.00%110.21M
PERCEPTIVE ADVISORS LLC10.31M2.87M+38.67%103.09M
JUPITER TOPCO LLC9.54M9.54MNew95.27M
VESTAL POINT CAPITAL, LP8.30M1.27M+18.15%83.00M
TWO SIGMA INVESTMENTS, LP6.78M382.72K+5.99%67.75M
GEODE CAPITAL MANAGEMENT, LLC6.25M465.27K+8.05%62.49M
ABERDEEN GROUP PLC5.31M270.20K+5.36%53.11M
UBS GROUP AG5.08M134.29K+2.72%50.78M
BANK OF AMERICA CORP /DE/4.80M-290.48K-5.70%48.01M
GOLDMAN SACHS GROUP INC4.48M2.13M+90.93%44.82M
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.4.01M00.00%40.09M
NUVEEN, LLC4.01M187.97K+4.92%40.07M
MILLENNIUM MANAGEMENT LLC3.39M3.21M+1708.39%33.95M
GW&K INVESTMENT MANAGEMENT, LLC3.17M-69.35K-2.14%31.71M
JANE STREET GROUP, LLC2.76M2.22M+406.88%27.63M
DIMENSIONAL FUND ADVISORS LP2.72M28.13K+1.05%27.19M
FISHER ASSET MANAGEMENT, LLC2.60M-129.23K-4.73%26.04M
RENAISSANCE TECHNOLOGIES LLC2.53M1.75M+225.65%25.30M
KYNAM CAPITAL MANAGEMENT, LP2.52M-3.16M-55.59%25.23M

Earnings and financials

BioCryst Pharmaceuticals, Inc. (BCRX) trades at $8.30, with a market cap of $2.12B and a trailing P/E of -5.32. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
2635300025186000206530004883500017812000157170000270827000331412000450712000874837000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

BioCryst Pharmaceuticals (BCRX) Financials: Revenue & Earnings

BCRX$8.30+0.20 +2.53%

$2.12B

Market Cap

-5.32

P/E

14.89

Forward P/E

—

Score

Price History